Purpose: The frequency of drug administration errors and incompatibilities between intravenous drugs before and after an intervention in an intensive care unit (ICU) is discussed. Methods ...

Rep. Jordan Redman, R-Coeur d’Alene, presented a bill Tuesday to add mifepristone and misoprostol to a list of Schedule IV ...

According to the Annual Report of National Adverse Drug Reaction Monitoring (2022) in China, adverse drug reactions (ADRs) related to intravenous administration accounted for 57.8% (2). Oral ...

429 medication administration errors were identified; giving an overall incidence of 19.1% (95% CI 17.5% to 20.7%) erroneous administrations. Errors in drug preparation were the most common, followed ...

This regulatory approval presents eligible patients with an effective, more convenient treatment option with faster administration times and reduced logistical burden, according to Dr. Eric K. Singhi.

Firstly, it was identified that existing clinical guidelines for IV-line site checking did not incorporate ergonomic principles to enable ... This scoping exercise identified that, at the time, no ...

The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...

A monthly 10 mg/mL maintenance dose of Leqembi had the same effects on mild Alzheimer’s symptoms as biweekly dose, research ...

The EC requests CHMP to reassess new safety data that emerged after the positive opinion recommending the approval of ...

Biogen and Eisai have won Food and Drug Administration approval of an intravenous maintenance dosing of their Leqembi drug for early Alzheimer's disease. The companies late Sunday said the FDA ...

Given the extremely small interior diameter of intravenous lines in tiny infants ... The majority of drugs used in our unit are listed in the Handbook on injectable drugs.18 However, there is limited ...

Proposed changes to this list are open for consultation. Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for ...